JPMorgan (NYSE:JPM) has resumed coverage on CEMEX (NYSE: CX), a global building materials company, assigning an Overweight rating with a price target of $8.00. The firm adjusted the target down from a previous $8.50, reflecting a 22% upside potential based on the current stock valuation. This new target is associated with a forward EV/EBITDA multiple of 5.0x, aligning with the industry's current valuation metrics.
The coverage update follows the release of CEMEX's second-quarter results, which met JPMorgan's expectations but revealed a less optimistic outlook for the second half of the year, particularly in terms of volume.
Consequently, the firm has reduced its EBITDA forecasts for fiscal years 2024 and 2025 by 3% and 6%, respectively. These revisions are primarily due to anticipated lower sales in Mexico and the United States, and the company's South and Central America region.
Despite the downward revision, JPMorgan anticipates a year-over-year EBITDA increase of 1% and a 4% rise on a like-to-like basis, in line with the company's guidance for low- to mid-single-digit growth.
The firm also projects stable profit margins at 19.4% and a flat revenue trajectory. Looking ahead to 2025, the analyst expects a 5% increase in EBITDA, a 0.4 percentage point margin expansion, and a 3% revenue growth, assuming a modest volume recovery and low single-digit price increases.
The analyst's outlook on the U.S. Construction Materials sector remains neutral but inclines towards a bearish perspective due to potential negative catalysts such as volume weakness, a higher likelihood of recession, and high valuations relative to historical norms. These factors could impact the sector through the end of the year and beyond.
Despite these concerns and the anticipated slowdown in Mexico's GDP growth, JPMorgan considers CEMEX's valuation extremely attractive. The firm acknowledges the company's recent strategic divestments, including the sale of assets in the Philippines and the Dominican Republic, as positive steps.
In other recent news, Cemex S.A.B. de C.V. has reported the divestiture of its Dominican Republic operations, valued at approximately $950 million, to Cementos Progreso and its partners. This strategic move is part of Cemex's broader objective to optimize its global asset portfolio and improve profitability.
InvestingPro Insights
As JPMorgan resumes coverage on CEMEX with an optimistic price target, the InvestingPro platform provides additional context to evaluate the company's financial health and market position. With a market capitalization of $9.49 billion and a forward-looking P/E Ratio (adjusted for the last twelve months as of Q2 2024) of 17.47, CEMEX appears to be trading at a significant earnings multiple. This aligns with JPMorgan's observation of high valuations within the industry. Moreover, the company's revenue growth for the same period stands at 7.77%, indicating a steady top-line expansion.
InvestingPro Tips highlight that CEMEX is a prominent player in the Construction Materials industry, with a strong return over the last five years. The company's management has been actively buying back shares, demonstrating confidence in its financial strategy. Additionally, analysts predict that the company will be profitable this year, supported by the expectation of net income growth. For investors looking for a deeper dive into CEMEX's potential, InvestingPro offers a suite of tips, with 9 additional insights available to help make informed decisions.
The strategic moves by CEMEX to divest certain assets and focus on strengthening its presence in the U.S. market are further reflected in its high shareholder yield. While the company does not pay a dividend, its shareholder return strategy is underscored by share repurchases. With a fair value estimated at $9.12 by InvestingPro, slightly below JPMorgan's target, investors may find CEMEX's current stock valuation an attractive entry point, especially considering the company's strong free cash flow yield implied by its valuation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.